Kraig Biocraft Laboratories Further Expands Spider Silk Production Levels with Launch of Third Production Cycle

Rhea-AI Summary

Kraig Biocraft Laboratories (OTCQB: KBLB) has launched its third and largest production cycle of spider silk for 2024. This expanded cycle, released in scheduled batches, aims to address the rainy season peak while driving towards 2024 production volume goals. The company has brought an additional production facility online to support increased silkworm rearing and silk production.

Kraig Labs expects to add more facilities over the next two months, supporting its goal of delivering the first metric ton of spider silk to global markets. Each production cycle further validates the company's spider silk production model and demonstrates its specialized silkworms' readiness for mass production. The company's CEO, Kim Thompson, described 2024 as an inflection point for spider silk commercialization.

Positive

• Launched third and largest production cycle of 2024
• Additional production facility brought online to expand capacity
• Plans to add more facilities in the next two months
• Aiming to deliver first metric ton of spider silk to global markets
• Validating spider silk production model for mass production

Negative

• None.

ANN ARBOR, Mich., July 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces the launch of its third and largest production cycle of the 2024 spider silk production season.

This cycle is being released in a set of scheduled batches, the first of which is already in production. This batch process is designed to address the upcoming peak of the rainy season while driving Kraig Labs toward its 2024 production volume goals.

This expanded production cycle was empowered by an additional production facility recently brought online. The Company is utilizing this newly constructed facility to support the continued expansion of silkworm rearing and silk production, avoiding the typical slowdowns due to rain.

Kraig Labs expects to bring additional facilities online over the next two months to increase its production footprint in support of its goal of delivering the first metric ton of spider silk to the global markets.

With each successive production cycle, the Company further validates its spider silk production model and that its specialized silkworms are ready for mass production. This now-fielded technology has broken through technical barriers, allowing for the large-scale commercial production of engineered spider silk using the cost-effective, time-tested, and established infrastructure for traditional silk.

"Our rearing operations continue to set new commercial spider silk production records. The first half of 2024 was a game-changer for the commercialization of spider silk, and we are expecting even greater things for the second half of the year," said Company Founder and CEO, Kim Thompson. "This year has been an inflection point for Kraig Labs and for the limitless possibilities of spider silk commercialization."

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

FAQ

What is Kraig Biocraft Laboratories' latest production milestone for spider silk in 2024?

Kraig Biocraft Laboratories (KBLB) has launched its third and largest production cycle of spider silk for the 2024 season, released in scheduled batches to address the rainy season peak and drive towards production volume goals.

How is Kraig Biocraft Laboratories (KBLB) expanding its spider silk production capacity?

KBLB has brought an additional production facility online to support increased silkworm rearing and silk production. The company plans to add more facilities over the next two months to further expand its production footprint.

What is Kraig Biocraft Laboratories' (KBLB) production goal for spider silk?

Kraig Biocraft Laboratories is working towards delivering the first metric ton of spider silk to global markets, which would be a significant milestone in the commercialization of spider silk.

How does Kraig Biocraft Laboratories (KBLB) produce spider silk commercially?

KBLB uses specialized silkworms engineered to produce spider silk. This technology allows for large-scale commercial production of engineered spider silk using the cost-effective and established infrastructure for traditional silk production.